Skip to content

What drugs does Cencora make? Uncovering a Pharmaceutical Distribution Giant

2 min read

Handling about 20% of all pharmaceuticals sold in the United States, Cencora is a pivotal force in the healthcare supply chain. So, a better question than 'What drugs does Cencora make?' is 'What drugs does Cencora distribute?'

Quick Summary

Cencora, formerly AmerisourceBergen, is a global pharmaceutical wholesaler, not a direct manufacturer. They distribute brand-name, generic, and specialty drugs from manufacturers to providers.

Key Points

  • Distributor, Not Manufacturer: Cencora's primary role is pharmaceutical distribution and sourcing, not drug manufacturing.

  • Vast Product Range: They distribute brand-name, generic, specialty, and over-the-counter drugs for both human and animal health.

  • Global Supply Chain: Cencora operates a massive global network of distribution centers and warehouses to ensure timely and secure medication delivery.

  • Formerly AmerisourceBergen: The company was known as AmerisourceBergen until it rebranded to Cencora in 2023.

  • Manufacturer Services: Beyond logistics, Cencora provides commercialization, clinical trial support, and regulatory consulting for drug manufacturers.

  • Provider Solutions: They offer pharmacies and hospitals services like inventory management and patient support programs.

  • Specialty Focus: A key area of their business is the distribution of specialty drugs that require complex handling, such as for oncology.

In This Article

Cencora's Core Business: Distribution, Not Manufacturing

Cencora, which rebranded from AmerisourceBergen in 2023, is a cornerstone of the global healthcare system, but its primary role is often misunderstood. The company does not manufacture drugs; instead, it's one of the largest pharmaceutical sourcing and distribution companies globally. Cencora serves as a critical link, connecting drug manufacturers with healthcare providers like hospitals and pharmacies. In 2023, its annual revenues reached $262 billion, highlighting its significant presence in the supply chain.

Its business model focuses on wholesale distribution and related services. They handle a vast range of products, including brand-name, generic, specialty drugs, and over-the-counter products. Cencora also has a significant animal health segment.

Services Beyond Distribution

Cencora provides extensive services throughout the drug lifecycle. For manufacturers, they offer commercialization support, including clinical trials, regulatory consulting, and market access. For providers, they offer solutions in practice management, inventory tracking, and patient programs. The company manages a global network of 55 specialized pharmaceutical warehouses with advanced controls.

Manufacturer vs. Distributor: A Key Distinction

Understanding the difference between a pharmaceutical manufacturer and a distributor is essential to grasp Cencora's role. A manufacturer develops and produces drugs, while a distributor, like Cencora, manages the logistics of getting those products to their destination.

Feature Pharmaceutical Manufacturer Pharmaceutical Distributor (Cencora)
Primary Role Research, develop, and produce new drugs. Source and distribute finished drugs.
Core Activities Clinical trials, chemical synthesis, formulation, packaging. Warehousing, logistics, inventory management, order fulfillment.
Relationship Creates the product. Connects the product to the provider.
Key Assets Laboratories, manufacturing plants, intellectual property (patents). Distribution centers, global logistics network, technology platforms.

What Kinds of Drugs Does Cencora Handle?

Cencora handles a vast catalog of pharmaceuticals. Their services cover almost every category, including biosimilars and specialty drugs for complex conditions like cancer and HIV. Examples of biosimilars they distribute include Tyenne and Mvasi. Their distribution network is crucial for delivering a wide range of medications, from common antibiotics to advanced therapies, safely and securely.

Conclusion

Cencora is a global leader in pharmaceutical distribution and healthcare solutions, not a drug manufacturer. It plays a vital role in the supply chain, ensuring medications from manufacturers reach healthcare providers worldwide. For more information on their role in the healthcare ecosystem, you can visit the {Link: Cencora website https://www.cencora.com/}.

Frequently Asked Questions

No, Cencora's business model is centered on pharmaceutical sourcing and distribution, not manufacturing. They are a wholesale company that connects drug manufacturers with healthcare providers.

Cencora was formerly known as AmerisourceBergen. The company officially changed its name and stock ticker symbol (COR) on August 30, 2023.

Cencora distributes a wide array of products, including brand-name and generic pharmaceuticals, over-the-counter (OTC) healthcare products, specialty drugs, and home healthcare supplies and equipment.

Yes, Cencora has a significant animal health division that distributes veterinary pharmaceuticals, vaccines, and diagnostic products through brands like MWI Animal Health.

Cencora distributes specialty drugs for complex conditions like oncology, rheumatology, and HIV. These often require special handling, such as temperature-controlled logistics.

Cencora is one of the largest pharmaceutical companies in the world by revenue, ranked #11 on the Fortune 500 with annual revenues of $262 billion in 2023. They handle about 20% of all pharmaceuticals distributed in the U.S..

Cencora provides extensive support to manufacturers, including services for clinical trial logistics, regulatory consulting, market access strategies, and full commercialization support to help bring products to market.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.